Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
Aim. To assess the effect of renal dysfunction on the galectin-3 level in patients with chronic heart failure (HF) with preserved, intermediate and reduced left ventricular ejection fraction (EF).Material and methods. Along with a clinical examination, 69 patients with HF (NYHA class II-IV) underwen...
Saved in:
| Main Authors: | V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Kazadaeva, Yu. G. Belyaev, A. V. Tolmacheva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2022-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2709 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT
by: E. A. Medvedeva, et al.
Published: (2017-02-01) -
CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE
by: Zh. D. Kobalava, et al.
Published: (2016-05-01) -
Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
by: Yu. B. Shchukin, et al.
Published: (2013-04-01) -
Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01) -
GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)